Health Professional Radio - Podcast
ESMO 2019 PAOLA Trial
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:06:30
- Mas informaciones
Informações:
Sinopsis
Returning guest Dr. Scot Ebbinghaus with Merck Research Labs discusses positive data presented at the European Society for Medical Oncology (ESMO) 2019 Congress on the phase 3 PAOLA-1 trial of Merck and AstraZeneca's LYNPARZA® (olaparib) added to Bevacizumab for newly diagnosed advanced ovarian cancer
